ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,848Medicare Part D Prescriptions Filled, Including Refills

Rank: 92 out of 252

$590K Total Retail Price of All Prescriptions

Rank: 76 out of 252

645 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 645 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 645 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

5% of this provider’s 8,158 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
LEVOTHYROXINE SODIUM 534 492 1 1
HYDROCODONE-ACETAMINOPHEN 389 247 S3 2 5
OMEPRAZOLE 306 279 3 6
LISINOPRIL 282 259 4 3
AMLODIPINE BESYLATE 270 253 5 4
PRAVASTATIN SODIUM 268 225 6 12
POTASSIUM CHLORIDE 207 176 7 8
ZOLPIDEM TARTRATE 207 155 7 21
MELOXICAM 179 169 9 20
HYDROCHLOROTHIAZIDE 172 145 10 13
METFORMIN HCL 168 152 11 9
ATENOLOL 159 133 12 18
FUROSEMIDE 145 113 13 7
SIMVASTATIN 144 137 14 2
GABAPENTIN 135 119 15 11
NEXIUM 130 119 16 23
METOPROLOL TARTRATE 124 106 17 10
ALENDRONATE SODIUM 122 119 18 32
WARFARIN SODIUM 115 113 19 14
ESTRADIOL 111 92 R 20 76
TRAZODONE HCL 110 77 21 31
LISINOPRIL-HYDROCHLOROTHIAZIDE 106 104 22 25
CITALOPRAM HBR 105 95 23 15
METOPROLOL SUCCINATE 97 78 24 19
TRAMADOL HCL 91 61 25 17
DONEPEZIL HCL 88 76 26 28
FLUOXETINE HCL 88 60 26 57
PREMARIN 88 85 R 26 116
ATORVASTATIN CALCIUM 87 87 29 16
GEMFIBROZIL 83 80 30 98
AMITRIPTYLINE HCL 73 73 R 31 46
EVISTA 72 68 32 91
TRIAMTERENE-HCTZ 66 54 33 33
LYRICA 65 47 34 66
VERAPAMIL ER 65 58 34 83
SYNTHROID 65 62 34 47
GLYBURIDE 64 37 R 37 78
LOVASTATIN 58 52 38 39
CARVEDILOL 55 42 39 22
CYCLOBENZAPRINE HCL 55 31 R 39 51
CARBIDOPA-LEVODOPA 54 54 41 107
PLAVIX 50 41 42 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 25, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.